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Background: Poor insight in schizophrenia has been theorised to reﬂect a cognitive deﬁcit that is secondary
to brain abnormalities, localized in the brain regions that are implicated in higher order cognitive functions,
including working memory (WM). This study investigated WM-related neural substrates of preserved and
poor insight in schizophrenia.
Method: Forty stable schizophrenia outpatients, 20 with preserved and 20with poor insight (usable data obtain-
ed from 18 preserved and 14 poor insight patients), and 20 healthy participants underwent functional magnetic
resonance imaging (fMRI) during a parametric ‘n-back’ task. The three groups were preselected tomatch on age,
education and predicted IQ, and the two patient groups to have distinct insight levels. Performance and fMRI data
were analysed to determine how groups of patients with preserved and poor insight differed from each other,
and from healthy participants.
Results: Poor insight patients showed lower performance accuracy, relative to healthy participants (p = 0.01)
and preserved insight patients (p = 0.08); the two patient groups were comparable on symptoms and medica-
tion. Preserved insight patients, relative to poor insight patients, showed greater activity most consistently in
the precuneus and cerebellum (both bilateral) during WM; they also showed greater activity than healthy
participants in the inferior–superior frontal gyrus and cerebellum (bilateral). Group differences in brain activity
did not co-vary signiﬁcantly with performance accuracy.
Conclusions: The precuneus and cerebellum function contribute to preserved insight in schizophrenia. Preserved
insight as well as normal-range WM capacity in schizophrenia sub-groups may be achieved via compensatory
neural activity in the frontal cortex and cerebellum.© 2013 The Authors. Published by Elsevier B.V. Open access under CC BY-NC-ND license.1. Introduction
Poor insight is one of the most frequently reported symptoms
of schizophrenia (Amador and David, 2004), with studies estimating
that about 50–80% of patients do not believe that they have a disorder
(Saeedi et al., 2007; Charkraborty and Basu, 2010). Much less is
known about the neurobiology of poor insight, relative to its clinical
consequences, in psychosis (Shad et al., 2007). At the neuropsychologi-
cal level, many, though not all, studies have shown executive function-
ing deﬁcits detected using the Wisconsin Card Sorting Test in patients, P078, Institute of Psychiatry,
F, UK. Tel.: +44 207 848 0233.
.Open access under CC BY-NC-ND licewith poor insight, somewhat similar to those observed in patients
with frontal lesions (Cooke et al., 2005). At the neural level, recent stud-
ies link poor insightwith greymatter alterations, mainly reductions, not
only in the frontal cortex (PFC), but also in the temporal and parietal
cortices, anterior and posterior cingulate, insula and the cerebellum
(Shad et al., 2007; Morgan et al., 2010; Palaniyappan et al., 2010;
Bergé et al., 2011; Raij et al., 2012), and with white matter deﬁcits in
frontal, temporal and parietal regions (Antonius et al., 2011).
According to themodel proposed by Shad et al. (2007), poor insight
in schizophrenia reﬂects a cognitive deﬁcit that is secondary to brain
abnormalities, localized in the frontal and other brain regions that are
implicated in higher order cognitive functions, including WM. WM,
the process of actively holding information “on-line” in the mind's eye
and manipulating it for guiding behaviour (Baddeley, 1992), is consid-
ered important for good insight in schizophrenia via its role in self-
monitoring and awareness of symptoms (Shad et al., 2007). In general,
schizophrenia patients show deﬁcient WM and aberrant brain activitynse.
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our knowledge, has yet investigated the activation of the WM neural
network in relation to preserved or poor insight in this population.
In this study, we aimed to investigate whether and how the groups
of patients with schizophrenia with preserved and poor insight differ
from each other, and from healthy participants, in brain activity elicited
by a parametric (n-back) working memory (WM) task, and detected
with functional magnetic resonance imaging (fMRI). The n-back task,
one of the most popular paradigms for functional neuroimaging studies
of WM, consistently activates the frontal and parietal cortical regions,
including the lateral premotor cortex, dorsal cingulate and medial
premotor cortex, dorsolateral and ventrolateral PFC, and medial and
lateral posterior parietal cortex (Owen et al., 2005). Here, we tested
the hypothesis, derived from the neurobiological model of insight
proposed by Shad et al. (2007), that patients with preserved insight,
compared to those with poor insight, will have stronger WM capacity
(Manoach, 2003) and this would be reﬂected as better performance
and a greater increase in prefrontal and parietal activity from low to
high WM load. The patients with preserved insight were expected to
perform and show fMRI activity within normal range, or only subtly
deﬁcient, relative to the healthy group. Poor insight patients were ex-
pected to show poor WM and deﬁcient neural activation, especially at
the highWM load likely to exceed theirWM capacity (Manoach, 2003).2. Methods
2.1. Participants and design
This study included 60 right-handed participants. Of these, 40 were
outpatients with schizophrenia, diagnosed using the Structured Clinical
Interview for DSM-IV (SCID) (First et al., 1995), and 20 were healthy
participants. Of 40 patients, selected out of an initial pool of 70 patients,
20 met the criterion for preserved and 20 for poor insight (described
further under ‘Clinical Assessment’ and ‘Classiﬁcation of Insight’). All in-
cluded patients were required to be a) on stable doses of antipsychotic
medication for ≥3 months, b) in the stable (chronic) phase of the
illness, and c) not within two years of illness onset. The two patientTable 1
Demographics, clinical characteristics and task performance of study participants.
Healthy participants
n = 20 (15M:5F)
Demographics Mean (SD) Range
Age (years) 31.95 (7.6) 20–47
Education (years) 14.90 (3.06) 10–20
Predicted IQ (NART)a 113.22 (10.17) 91–12
Clinical characteristics
BIS insight score
Age at illness onset (years)
Positive symptomsb
Negative symptomsb
General psychopathologyb
Total symptomsb
Medication (chlorpromazine equivalents in mg)
Performance Mean (SEM)
Accuracy (%) (chance performance = 25%) 0-Back 88.42 (2.05)
1-Back 75.19 (5.03)
2-Back 52.47 (5.72)
Reaction time (ms) 0-Back 187.57 (33.05)
1-Back 261.49 (34.34)
2-Back 394.38 (56.33)
Duration of illness = current age minus age of illness onset.
a National Adult Reading Test.
b PANSS: Positive and Negative Symptom Scale.groups were selected to be closely matched on age, sex and predicted
IQ assessed using the National Adult Reading test (NART) (Nelson and
Willison, 1991). Included healthy participantswere screened to exclude
neuropsychiatric conditions and matched for age, sex and predicted
IQ of the patient sample. The study procedures had approval of the
ethics committee of the Institute of Psychiatry and South London and
Maudsley NHS Foundation Trust, London. All participants provided
written informed consent and were compensated for their time and
travel.
Of 20 patients with preserved insight, two patients had signiﬁcant
movement artefacts (i.e. rotations larger than 5° or translations greater
than 5 mm) during fMRI and were excluded. Of 20 patients with poor
insight, six patients were excluded because of movement artefacts
(n = 2) or a failure to comply with given task instructions (n = 4).
The ﬁnal sample thus included 18 preserved insight and 14 poor insight
patients, and 20 healthy participants. Table 1 shows demographic and
clinical characteristics of the groups.2.2. Clinical assessment
Insight in patients was assessed using a self-rated instrument, the
Birchwood insight scale (BIS) (Birchwood et al., 1994). The BIS assesses
David's (1990) three dimensions of insight, namely (i) the presence of a
mental illness (items 2 and 7), (ii) the need for treatment (items 3–6),
and (iii) the identiﬁcation of symptoms as abnormal (items 1 and 8).
As we did not include inpatients, item 4 “My stay in hospital is neces-
sary” was excluded. Each item of the BIS is rated as ‘agree’, ‘disagree’
or ‘unsure’, giving an item score of 1 for unsure, and 0 or 2 for agree
and disagree, depending on whether agreement with the statement
indicates good insight; the items are counterbalanced for response
valence. The BIS yields a maximum score of 16 (for this study, a maxi-
mum score of 14 after exclusion of item 4)with higher scores indicating
better insight. The BIS has adequate internal consistency (α = 0.75)
and satisfactory test–retest reliability (r = 0.90 for the total insight
score) (Birchwood et al., 1994). Insight assessed on the BIS correlates
positively with other insight measures (Sapara et al., 2007). Patients
completed the BIS under supervision. Symptoms were rated by aPatients
Preserved insight n = 18 (14M:4F) Poor insight n = 14; (9M = 5F)
Mean (SD) Range Mean (SD) Range
35.3 (9.92) 19–52 37.7 26–49
13.72 (2.89) 9–20 13.00 (1.35) 11–17
8 108.66 (10.51) 86–122 106.76 (8.38) 90–119
13.78 (0.43) 13–14 5.0 (2.04) 1–8
24.95 (9.24) 12–48 22.36 (6.12) 10–33
16.17 (5.07) 8–24 15.71 (4.75) 7–22
16.83 (4.12) 7–25 19.29 (5.65) 8–27
33.50 (5.44) 24–42 32.29 (6.33) 21–40
66.50 (11.91) 43–83 67.29 (14.53) 37–86
459.93 (363.67) 100.00–1600.00 497.07 (348.63) 200–1367
Mean (SEM) Mean (SEM)
89.85 (3.04) 84.10 (4.68)
71.90 (6.99) 54.69 (7.46)
51.37 (7.10) 34.73 (6.08)
215.05 (33.18) 242.70 (36.79)
302.80 (36.68) 319.43 (53.36)
532.99 (68.14) 482.58 (82.95)
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(PANSS) (Kay et al., 1987).
2.3. Classiﬁcation of insight
Birchwood et al. (1994) suggested a BIS score of 9 as the cut off for
good clinical insight. In this study, we deﬁned scores ≥13 as preserved
insight, and ≤8 as poor insight, to ensure that the two groups had
clearly distinct insight levels.
2.4. fMRI: Paradigm and procedure
The task involved monitoring locations of dots (presentation time:
450 ms; inter-stimulus-interval: 1500 ms) within a diamond shaped
box on the screen at a given delay from the original occurrence (0-back,
1-back, or 2-back) (Kumari et al., 2009). There were three 30-s active
conditions (0-back, 1-back, 2-back), presented ﬁve times in pseudoran-
dom order, controlling for order effect. Each active block had 15 stimulus
presentations, starting with a 15 s rest block (‘Rest’ on the screen), and
began with a 750 ms text delay to allow the participants to notice a
change in task demand/condition. Participants viewed the paradigm
projected onto a screen via a prismatic mirror whilst lying in the scanner.
They were required to press the button on every trial, using the right
thumb, corresponding to the correct location of the 0-back (current),
1-back (previous) or 2-back (previous but one) stimulus (chance
performance = 25%; location of dots random).
Participants were requested to abstain from alcohol for at least 24 h
prior to their scanning and given a chance to practice once on the task in
advance of the scheduled scan to familiarize themwith the procedures.
2.5. fMRI data acquisition
Echoplanar MR brain images were acquired using a 1.5 T GE
Signa system (General Electric, Milwaukee WI, USA). In each of 16
near-axial non-contiguous planes parallel to the inter-commissural
plane, T2*-weighted MR images depicting blood-oxygen-level-
dependent contrast (Ogawa et al., 1990) were acquired over the experi-
ment with echo time (TE) = 40 ms, repetition time (TR) = 3 s, in-
plane resolution = 3.1 mm, slice thickness = 7.0 mm, and interslice
gap = 0.7 mm. In the same session, a high-resolution 3-D inversion
recovery prepared spoiled GRASS volume dataset was acquired with
TE = 5.3 ms, TI = 300 ms, TR = 12.2 ms, in-plane resolution = 0.94
mm, and slice thickness = 1.5 mm.
2.6. Statistical analyses
2.6.1. Demographic, clinical and behavioural measures
Possible group differences in age, education and IQ (NART) were
examined using a one-way analysis of variance (ANOVA) with Group
as a between-subjects factor. Differences in clinical variables (insight,
age at illness onset, symptoms) between the preserved and poor insight
patient groups were examined using independent sample t-tests.
Group differences in performance were examined by a Group
(preserved insight patients, poor insight patients, healthy
participants) × Load (0-back, 1-back, 2-back) ANOVA [separately
for accuracy (percentage correct responses) and latency (in ms)
of correct responses] with Group as a between-subjects factor
and Load as the within-subjects factor, followed by analysis of lower
order effects as appropriate. Effect sizes for group differences in
performance were estimated as partial eta2 (the proportion of variance
associated with a factor).
Data were analysed using SPSS 20.0 for Windows. The alpha level
for signiﬁcance (2-tailed) was set at p b 0.05 unless stated otherwise.
Prior to conducting the analyses described above, the data were
examined to ensure that statistical assumptions required were met.2.6.2. Functional MRI
2.6.2.1. Image pre-processing. For each participant, the 225 volume
functional time series were motion corrected (Friston et al., 1996),
transformed into stereotactic space, spatially smoothed with a 8 mm
FWHMGaussianﬁlter and bandpassﬁltered using statistical parametric
mapping software (SPM5; http://www.ﬁl.ion.ucl.ac.uk/spm).
2.6.2.2. Models and statistical inferences.Datawere analysed using a two-
stage randomeffect procedure (Friston et al., 1999). Theﬁrst stage iden-
tiﬁed subject-speciﬁc activations in all participants with a factorial
model consisting of three active conditions (0-back, 1-back, 2-back)
and rest as the implicit baseline. The boxcar for each 30-s epoch was
convolved with the haemodynamic response function, global signal
changes were removed and the time series were processed using a
high-pass ﬁlter (128 s) to remove low-frequency artefacts. Generic
task related activations in each group were identiﬁed (activation maps
thresholded at p b 0.005; FWE-corrected at the cluster level, p b 0.05)
for each of the active condition versus rest, 1-back and 2-back versus
0-back, and 2-back versus 1-back contrasts using one-sample t-tests.
The second stage of analysis involved separate ANOVAs within SPM5,
for each of the active condition versus rest, 1-back and 2-back versus
0-back, and 2-back versus 1-back contrasts, with Group as a between-
subjects factor. These SPM ANOVAs were used to identify regions
(height threshold p b 0.005, FWE-corrected at the cluster level
p b 0.05) differentiating two or more groups using planned contrasts
(each of the two patient groups vs the healthy group, poor and high
insight patient group against each other). Analysis of some con-
trasts showed signiﬁcant group differences only at the uncorrected
level; these are also reported where the group difference occurred
within regions linked to the WM network identiﬁed in previous
studies.
Next, the subject-speciﬁc activation contrast image values were
extracted (from one-sample tests including all participants) for the
regions (peak voxel) differentiating the patient groups from each
other, and from the healthy group, and examined for their possible rela-
tionships with performance (run within the SPSS) ﬁrst using ANOVA
with brain activity as the dependent variable and relevant Groups as
the between-subjects variable, and then, in order to understand the
contribution of (varying) performance to differences in brain activity
of the three study groups, using analysis of co-variance (ANCOVA)
with brain activity as the dependent variable, relevant Groups as the
between-subjects variable, and performance accuracy over ﬁve blocks
of 0-back (for 0-back N rest contrast), 1-back (for 1-back N 0-back/
rest contrasts) or 2-back trials (for 2-back N 1back/0-back/rest con-
trasts) as the covariate.
3. Results
3.1. Demographic, clinical and behavioural measures
The ﬁnal three study groups did not differ signiﬁcantly in age
[F(2,49) = 1.97, p = 0.15], education [F(2,49) = 2.527, p =0.12],
and NART IQ [F(2,49) = 1.99, p = 0.15] (Table 1).
The preserved and poor insight patient groups were comparable
in age at illness onset [t (30) = 0.90, p = 0.37], positive symptoms
[t(30) = 0.26, p = 0.80], negative symptoms [t(30) = 1.42, p = 0.17],
general psychopathology [t(30) = 0.58, p = 0.56], and total PANSS
symptoms [t(30) = 0.17, p = 0.87]. The groups were also taking similar
doses of antipsychotic medication [t(30) = 0.31, p = 0.76]. By design,
the two groups differed highly signiﬁcantly in the level of insight
[t(30) = 13.76, p b 0.001].
For performance accuracy, there was a highly signiﬁcant effect
of Load [F(2,98) = 79.44, p b 0.001; pta2 = 0.62], indicating lower
accuracy at higher memory load in all groups (Table 1). There was
also a marginally signiﬁcant main effect of Group [F(2,49) = 3.08,
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in poor insight patients, compared to preserved insight patients
[F(1,30) = 3.23, p = 0.08, pta2 = 0.01] and healthy participants
[F(1,32) = 6.70, p = 0.01, pta2 = 0.17]; preserved insight patients
did not differ from healthy participants [F(1,36) = 0.15, p = 0.70].
The Group × Load interaction was not signiﬁcant [F(4,98) = 1.37,
p = 0.25].
For reaction time (to correct responses), there was only a signif-
icant main effect of Load [F(2,98) = 30.66, p b 0.001; pta2 = 0.39],
indicating longer reaction time at higher memory load in all three
groups (Table 1). There was no effect of Group [F(2,49) = 1.32,
p = 0.28] or Group × Load interaction [F(4.98) = 0.74, p = 0.49].Fig. 1. Figure shows clusters of signiﬁcant activity during active task conditions in the three stud
each slice is given on the left of images. Right of image = left hemisphere.3.2. Functional MRI
3.2.1. Generic task related activations
Task related activations for each group are listed in Appendix 1
(supplementary materials) and displayed in Fig. 1. The activations,
including fronto-parietal–cerebellar regions, in the healthy group
were highly consistent with previous studies using this task (Kumari
et al., 2006, 2009). The preserved insight group also showed signiﬁcant
activation of many of the same areas that were active in the healthy
group. The poor insight group, however, showed activation in fewer
clusters and did not show signiﬁcant activation of any brain area during
the 1-back and 2-back conditions, relative to the 0-back condition.y groups (height threshold p b 0.005; cluster p b 0.05 corrected). TheMNI Z co-ordinate of
Table 2
Areas showing group differences (height threshold p b 0.005) in activity to task demands.
BA Cluster size (voxels) Side MNI coordinates Voxel T value Cluster p
(corrected unless shown in italics)
X Y Z
Preserved insight vs poor insight patients
Preserved insight patients N poor insight patients
2-Back N rest
Precuneus 7 439 Right 6 −52 50 4.33 0.047
Left −8 −40 52 2.96
Cerebellum n/a 1489 Right 22 −42 −24 3.83 0.010
Left −10 −46 −24 3.73
Right 6 −48 −22 3.46
2-Back N 1-back
Cerebellum n/a 821 Right 10 −42 −36 4.06 0.007
Left −10 −58 −30 3.89
Right 6 −56 −32 3.81
Precuneus 7 949 Right 2 −52 50 3.94 0.044
Left −22 −70 60 3.72
Left −4 −66 50 3.56
Poor insight patients N preserved insight patients
None signiﬁcant in any contrasts
Poor insight patients vs healthy participants
Poor insight patients N healthy participants
1-Back N rest
Inferior frontal gyrus 45 389 Left −38 26 12 3.96 0.030
Left −44 18 12 3.71
Left −48 36 14 2.90
Middle frontal gyrus 46 391 Right 48 18 20 3.46 0.030
Inferior frontal gyrus 45 Right 54 18 12 3.31
Right 44 32 16 2.88
Healthy participants N poor insight patients
2-Back N 0-back
Cerebellum n/a 686 Right 6 −48 −22 3.50 0.027
Right 6 −64 −18 3.33
Left −12 −46 −24 2.98
Preserved insight patients vs healthy participants
Preserved insight patients N healthy participants
0-Back N rest
Inferior frontal gyrus 45 4373 Right 48 20 18 5.09 b0.001
Left −22 38 30 4.56
Right 52 18 34 4.19
Cerebellum 1098 Right 2 −50 2 4.56 0.025
Precuneus 31 Right 4 −44 38 3.62
Posterior cingulate 23 Right 2 −40 24 3.05
1-Back N rest
Inferior frontal gyrus 46 356 Right 46 32 8 3.94 0.037
2-Back N rest
Cerebellum n/a 1039 Left −38 −54 −22 4.22 0.042
Left −36 −62 −22 4.20
Superior frontal gyrus 9 487 Right 16 56 24 3.55 0.038
Right 16 32 30 3.28
Right 18 56 34 2.99
2-Back N 1-back
Superior frontal gyrus 10 450 Right 16 54 22 3.74 0.036
Left −16 50 22 3.58
Left −2 42 26 3.25
Healthy participants N preserved insight patients
None signiﬁcant in any contrasts.
BA = Brodmann Area.
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Group differences in task related activations are noted in Table 2.
3.2.2.1. Preserved insight vs poor insight patients. Preserved insight
patients, compared to those with poor insight, showed greater activity
in the precuneus and cerebellum (both bilateral) during 2-back N rest
and 2-back N 1-back contrasts (Table 2; Fig. 2). Poor insight patients,
compared to preserved insight patients, did not show greater activity
in any brain areas during any of task conditions.
3.2.2.2. Poor insight patients vs healthy participants. Compared to healthy
participants, poor insight patients showed greater activations onlyduring low WM load (1-back N rest), and these were observed in the
inferior (bilateral) and middle (right) frontal gyri.
Healthy participants, in comparison with poor insight patients,
showed greater cerebellar activations during the 2-back N 0-back
(bilateral) contrast.
3.2.2.3. Preserved insight patients vs healthy participants. Many brain
areas were activated to a greater extent in preserved insight patients,
compared with healthy participants. For the 0-back N rest contrast,
these included the inferior frontal gyrus (bilateral), cerebellum,
precuneus and posterior cingulate (all right-sided). The preserved in-
sight group also showed greater activation of the inferior frontal gyrus
Fig. 2. Axial sections of a standard brain with areas of greater activity in the preserved insight group, compared to the poor insight and healthy participant groups superimposed
(height threshold p b 0.005, cluster p b 0.05 uncorrected). The MNI Z co-ordinate of each slice is given below each image. Right of image = left hemisphere.
Table 3
ANOVAs and ANCOVAs of group differences in cerebral activity for each working memory load with change in response accuracy as a covariate.
Group comparison Contrast Brain region MNI ANOVA ANCOVA
(with % correct
as a covariate)
Side X Y Z BA F(1,30) p F(1,29) p
Preserved insight N poor insight patients 2-Back N rest Precuneus Right 6 −52 50 7 18.54 b0.001 13.75 0.001
Cerebellum Right 22 −42 −24 n/a 15.96 b0.001 13.24 0.001
2-Back N 1-back Cerebellum Right 10 −42 −36 n/a 13.77 0.001 9.82 0.004
Precuneus Right 2 −52 50 7 11.00 0.002 7.24 0.012
F(1,32) p F(1,31) p
Poor insight patients N healthy participants 1-Back N rest Inferior frontal gyrus Left −38 26 12 45 12.53 0.001 13.88 0.001
Middle frontal gyrus Right 48 18 20 46 13.82 0.001 16.07 b0.001
F(1,32) p F(1,31) p
Healthy participants N poor insight patients 2-Back N 0-back Cerebellum Right 6 −48 −22 n/a 11.27 0.002 7.93 0.008
F(1,36) p F(1,35) p
Preserved insight patients N healthy participants 0-Back N rest Inferior frontal gyrus Right 48 20 18 45 23.80 b0.001 23.07 b0.001
Cerebellum Right 2 −52 2 n/a 23.57 b0.001 22.88 b0.001
1-Back N rest Inferior frontal gyrus Right 46 32 8 46 13.85 0.001 15.27 0.001
2-Back N rest Cerebellum Left −38 −54 −22 n/a 12.73 0.001 12.26 0.001
Superior frontal gyrus Right 16 56 24 9/10 14.82 0.001 14.07 0.001
2-Back N 1-back Superior frontal gyrus Right 16 54 22 10 14.180 0.001 14.64 0.001
BA = Brodmann Area.
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superior frontal gyrus (right) for the 2-back N rest contrast; and of the
superior frontal gyrus (bilateral) for the 2-back N 1-back contrast.
Healthy participants, compared to preserved insight patients, did
not show greater activation in any area during any of the contrasts.
3.2.2.4. Group differences in brain activations co-varying for performance.
As shown in Table 3, earlier-described group differences in task related
activations did not co-vary with relevant performance accuracy
measure. The strength of group difference was only minimally affected
by co-varying for performance.
4. Discussion
Focussing on the neurobiology of preserved and poor insight in psy-
chosis, we tested the hypothesis that patients with preserved insight,
compared with those with poor insight, have stronger WM capacity
and greater increases in fMRI activity in the prefrontal and parietal
cortices from low to high WM load. Preserved insight patients were
expected to perform and show fMRI activity broadly similar to those
of the healthy group.
Behaviourally, performance declined with increasingWM load in all
groups, as seen previously on this task (Kumari et al., 2006, 2009). Im-
portantly, supporting the theorised association between a WM deﬁcit
and poor insight in schizophrenia (Shad et al., 2007), only poor insight
patients, relative to healthy participants, showed signiﬁcantly poor
performance accuracy; preserved insight patients did not differ from
healthy participants in performance accuracy. Impaired performance
of poor insight patientsmost likely resulted from their lowWMefﬁcien-
cy (as discussed later) though itmay also reﬂect, at least to some extent,
a lack of effort on their part. Poor WM is a common ﬁnding in schizo-
phrenia (Reichenberg and Harvey, 2007). Our ﬁndings indicate that
this may be particularly true for poor insight patients. The trend-level
difference in performance of the low and high insight groups, despite
them being comparable on premorbid IQ and symptoms (Table 1),
may suggest a stronger association between WM and insight than
between premorbid IQ and insight.
At the neural level, preserved insight patients, compared with poor
insight patients, showed higher brain activity during the 2-back condi-
tion (relative to both the rest and 1-back condition) in the precuneus
and cerebellum (bilateral). Poor insight patients, compared with pre-
served insight patients, did not show greater activity in any brain area.
Since the differences observed inmagnitude of brain activation between
the twopatient groups (i.e. higher activity in preserved insight patients)
were not abolished after co-varying for performance (Table 3), and the
two patients groups had comparable age, years of education and IQ
scores (Table 1), they aremost likely to be explained by differing insight
levels of the two groups. We now discuss the meaning of these various
brain-insight associations in turn.
Our ﬁnding of the precuneus–insight association has support from a
previous structural MRI investigation which showed a direct positive
correlation between insight and the left precuneus grey matter volume
in psychosis (Cooke et al., 2008) and a recent single photon emission
computed tomography study showing greater perfusion of the
precuneus in patients with preserved insight (Faget-Agius et al.,
2012). The observations of a number of recent studies in healthy people
concerning precuneus function allowus to postulate how itmight play a
role in preservation of insight in psychosis. Speciﬁcally, a network in-
volving this brain area has been put forward as themechanism through
which personal identity and past personal experiences are interlinked,
allowing a person to move between representation and awareness of
the self (Andreasen et al., 1995). Functional imaging studies have
shown a) precuneus activity when comparing self to non-self represen-
tations (Kircher et al., 2000, 2002) and when participants reﬂect about
their own personality traits and physical appearance (Kjaer et al.,
2002), and b) a linear relationship between precuneus activity andthe degree to which the retrieval of previous psychological traits was
self-referential (Lou et al., 2004). These observations indicate that
the precuneus is either involved in assigning ﬁrst-person perspective
(e.g. awareness of one's own mental states) (Vogeley and Fink, 2003),
or more generally in internal representation through mental imagery
and episodic/autobiographical memory retrieval (Cavanna and Trimble,
2006). An inability to access representations of his/her ownmental states
may prevent a patient from identifying that his/her mental states are
problematic.
To our knowledge, ours is the ﬁrst study to ﬁnd an association be-
tween cerebellum activity and preserved insight but it is in line with
ﬁnding of a recent study (Bergé et al., 2011) showing a positive relation-
ship between cerebellum grey matter volume and insight in psychosis.
The group differences we observed in cerebellum activity were some-
what reduced though not abolished after co-varying for performance,
meaning that they probably arose from both insight and WM-related
differences, the two themselves being related. Patients with cerebellar
damage are reported to show intellectual and socio-emotional dysfunc-
tion (Schmahmann, 1991) and mild-to-moderate WM impairment
(Timmann and Daum, 2007) whilst neuroimaging studies suggest
cerebellum involvement in WM (Hayter et al., 2007) and the cere-
bellum is both clinically and cognitively implicated in schizophrenia
(Picard et al., 2008). According to the model of Andreasen et al.
(1999), disruption in the cortico–cerebellar–thalamo–cortical circuitry
results in deﬁcient processing, prioritising, retrieval, coordination, and
responding to information, i.e. ‘cognitive dysmetria’, in schizophrenia.
Our ﬁndings suggest that this circuitry may also have a role in insight
in schizophrenia.
In addition to showing higher activity than the poor insight group
(discussed above), the preserved insight group also showed greater
brain activity in many areas including the PFC and cerebellum in com-
parison to the healthy group during all active conditions, including the
2-back. These observed activation patterns may suggest that preserved
insight and normal-range WM capacity in this patient group may have
been achieved via compensatory neural activity (Ettinger et al., 2011).
Interestingly, the poor insight group, compared with the healthy
group, also showed a trend towards greater activity (an uncorrected
level of signiﬁcance) in some regions but only during the 1-back condi-
tion, consistent with previous suggestions (Manoach, 2003) that indi-
viduals with lower WM capacity require much greater neuronal
activity to maintain performance at a lower WM load. The poor insight
group displayed no further increase from 0-back, and 1-back, to 2-back
(higher load) condition (Appendix 1), further indicating a lower WM
capacity in these patients. Additionally, the poor insight group showed
a trend towards lower cerebellum activity compared with the healthy
group during the 2-back condition, consistentwith the earlier discussed
role of cerebellum in schizophrenia.
The ﬁndings of the present study have clinical implications. For
example, it may be possible to improve insight in schizophrenia by
cognitive training to improveWM (McGurk et al., 2005) and functioning
of the associated brain regions (Wykes et al., 2002). Insight is already
known to predict treatment outcome and long-term prognosis
(Amador and David, 2004; Charkraborty and Basu, 2010) and recent
data indicate that PFC and cerebellum function is also predictive of
clinical outcome following cognitive behaviour therapy for psychosis
(Kumari et al., 2009).
The present study has a number of strengths. Firstly, the preserved
and poor insight groups examined had clearly distinct levels of insight
(although preselected on total BIS score, the preserved insight group
had signiﬁcantly higher scores on all three BIS dimensions) and the
groups were closely matched for age, education and predicted IQ.
Secondly, the study utilised a well-researched and well-established
WMparadigmwhich has been used inmany previous studies of schizo-
phrenia patients and thus allows meaningful inferences to be drawn
about the observed activation patterns in the preserved and poor
insight groups.
208 A. Sapara et al. / Schizophrenia Research 152 (2014) 201–209The present study, however,was notwithout some limitations. First-
ly, although 20 patients were initially recruited in each insight group, 6
poor insight patients had to be excluded resulting in a reduced sample
size for this group, and the possibility of a Type-II error. In addition to
the loss of 2/20 patients/group due to movement artefacts, 4 poor in-
sight patients were excluded because of their poor compliance with
task instructions during fMRI. As these procedural errors occurred
in the poor insight group, they could possibly be due to their low WM
capacity affecting their ability to execute the task. Interestingly, two of
these poor insight patients persisted with initial set (0-back) of instruc-
tions throughout the entire task despite having practised with instruc-
tions provided prior to the fMRI scan. This could be viewed as a form
of procedural perseveration in poor insight patients, impairing their ca-
pacity to perform successfully on the n-back task. Secondly, this study
included outpatients maintained on antipsychotic medication which is
known to impact on WM activations in schizophrenia (Ettinger et al.,
2011). However, as the patient groupswere largely comparable inmed-
ication use, age at illness onset and general symptomatology, the results
observed should be interpreted in terms of difference in insight levels.
Thirdly, this study utilised a block, rather than an event related, fMRI
design, which does not allow us to examine group differences in neural
activity in only correct trials. Lastly, sinceWM is not a direct measure of
insight, activity differences between lowand high insight groups seen in
this study may include inﬂuences unrelated to insight differences.
5. Conclusion
This study provides direct empirical support for the theorised link
betweenWMdysfunction and poor insight across the three dimensions
measured with the BIS in schizophrenia. Furthermore, the ﬁndings
demonstrate involvement of the WM neural network, in particular of
the precuneus and cerebellum, as being involved in the preservation
of insight in schizophrenia patients, and suggest that preserved insight
as well as normal-range WM capacity in schizophrenia sub-groups
may be achieved via compensatory neural activity in the frontal cortex
and cerebellum.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.schres.2013.11.026.
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